Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase

Friederike H C Engels, Daniel Kreisel, Mark B. Faries, Isabelle Bedrosian, Gary K. Koski, Peter A Cohen, Brian J. Czerniecki

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We have previously demonstrated that Ph+ myeloid progenitor cells of patients with chronic myeloid leukemia (CML) can acquire characteristics of mature dendritic cells (DC) following calcium mobilization with calcium ionophore (A23187, CI). In this study we characterize the intracellular signaling pathway by which CI induces the acquisition of DC features in these leukemic cells. CI-induced activation of CML cells is attenuated by the calcineurin phosphatase inhibitor cyclosporin A (CsA) as well as the calmodulin (CaM) antagonist W-7. These cause ablation of both the CI-induced immunophenotypic expression of DC markers and immunostimulatory properties in mixed leukocyte responses (MLR). Minimal blocking effect was observed when Ca2+/CaM kinase II (281-301) inhibitor was added to the cultures. These findings suggest a Ca2+-dependent mechanism for the CI-induced activation of CML cells into antigen-presenting cells (APC), which is primarily mediated through the CaM/calcineurin pathway. Copyright (C) 2000 Elsevier Science Ltd.

Original languageEnglish (US)
Pages (from-to)795-804
Number of pages10
JournalLeukemia Research
Volume24
Issue number10
DOIs
StatePublished - Oct 2000
Externally publishedYes

Fingerprint

Calcium Ionophores
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Dendritic Cells
Stem Cells
Myeloid Cells
Calmodulin
Myeloid Progenitor Cells
Calcium-Calmodulin-Dependent Protein Kinases
Calcineurin
Calcimycin
Antigen-Presenting Cells
Cyclosporine
Leukocytes
Calcium
calcineurin phosphatase

Keywords

  • Ca/calmodulin kinase II (281-301)
  • Calmodulin/calcineurin pathway
  • Chronic myelogenous leukemia (CML)
  • Cyclosporin A (CsA)
  • Dendritic cells (DC)
  • Inhibitory effect
  • Myeloid progenitor cells
  • W-7

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase. / Engels, Friederike H C; Kreisel, Daniel; Faries, Mark B.; Bedrosian, Isabelle; Koski, Gary K.; Cohen, Peter A; Czerniecki, Brian J.

In: Leukemia Research, Vol. 24, No. 10, 10.2000, p. 795-804.

Research output: Contribution to journalArticle

Engels, Friederike H C ; Kreisel, Daniel ; Faries, Mark B. ; Bedrosian, Isabelle ; Koski, Gary K. ; Cohen, Peter A ; Czerniecki, Brian J. / Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase. In: Leukemia Research. 2000 ; Vol. 24, No. 10. pp. 795-804.
@article{ca20096156a54e859ae09ceca39ee2a4,
title = "Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase",
abstract = "We have previously demonstrated that Ph+ myeloid progenitor cells of patients with chronic myeloid leukemia (CML) can acquire characteristics of mature dendritic cells (DC) following calcium mobilization with calcium ionophore (A23187, CI). In this study we characterize the intracellular signaling pathway by which CI induces the acquisition of DC features in these leukemic cells. CI-induced activation of CML cells is attenuated by the calcineurin phosphatase inhibitor cyclosporin A (CsA) as well as the calmodulin (CaM) antagonist W-7. These cause ablation of both the CI-induced immunophenotypic expression of DC markers and immunostimulatory properties in mixed leukocyte responses (MLR). Minimal blocking effect was observed when Ca2+/CaM kinase II (281-301) inhibitor was added to the cultures. These findings suggest a Ca2+-dependent mechanism for the CI-induced activation of CML cells into antigen-presenting cells (APC), which is primarily mediated through the CaM/calcineurin pathway. Copyright (C) 2000 Elsevier Science Ltd.",
keywords = "Ca/calmodulin kinase II (281-301), Calmodulin/calcineurin pathway, Chronic myelogenous leukemia (CML), Cyclosporin A (CsA), Dendritic cells (DC), Inhibitory effect, Myeloid progenitor cells, W-7",
author = "Engels, {Friederike H C} and Daniel Kreisel and Faries, {Mark B.} and Isabelle Bedrosian and Koski, {Gary K.} and Cohen, {Peter A} and Czerniecki, {Brian J.}",
year = "2000",
month = "10",
doi = "10.1016/S0145-2126(00)00047-3",
language = "English (US)",
volume = "24",
pages = "795--804",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase

AU - Engels, Friederike H C

AU - Kreisel, Daniel

AU - Faries, Mark B.

AU - Bedrosian, Isabelle

AU - Koski, Gary K.

AU - Cohen, Peter A

AU - Czerniecki, Brian J.

PY - 2000/10

Y1 - 2000/10

N2 - We have previously demonstrated that Ph+ myeloid progenitor cells of patients with chronic myeloid leukemia (CML) can acquire characteristics of mature dendritic cells (DC) following calcium mobilization with calcium ionophore (A23187, CI). In this study we characterize the intracellular signaling pathway by which CI induces the acquisition of DC features in these leukemic cells. CI-induced activation of CML cells is attenuated by the calcineurin phosphatase inhibitor cyclosporin A (CsA) as well as the calmodulin (CaM) antagonist W-7. These cause ablation of both the CI-induced immunophenotypic expression of DC markers and immunostimulatory properties in mixed leukocyte responses (MLR). Minimal blocking effect was observed when Ca2+/CaM kinase II (281-301) inhibitor was added to the cultures. These findings suggest a Ca2+-dependent mechanism for the CI-induced activation of CML cells into antigen-presenting cells (APC), which is primarily mediated through the CaM/calcineurin pathway. Copyright (C) 2000 Elsevier Science Ltd.

AB - We have previously demonstrated that Ph+ myeloid progenitor cells of patients with chronic myeloid leukemia (CML) can acquire characteristics of mature dendritic cells (DC) following calcium mobilization with calcium ionophore (A23187, CI). In this study we characterize the intracellular signaling pathway by which CI induces the acquisition of DC features in these leukemic cells. CI-induced activation of CML cells is attenuated by the calcineurin phosphatase inhibitor cyclosporin A (CsA) as well as the calmodulin (CaM) antagonist W-7. These cause ablation of both the CI-induced immunophenotypic expression of DC markers and immunostimulatory properties in mixed leukocyte responses (MLR). Minimal blocking effect was observed when Ca2+/CaM kinase II (281-301) inhibitor was added to the cultures. These findings suggest a Ca2+-dependent mechanism for the CI-induced activation of CML cells into antigen-presenting cells (APC), which is primarily mediated through the CaM/calcineurin pathway. Copyright (C) 2000 Elsevier Science Ltd.

KW - Ca/calmodulin kinase II (281-301)

KW - Calmodulin/calcineurin pathway

KW - Chronic myelogenous leukemia (CML)

KW - Cyclosporin A (CsA)

KW - Dendritic cells (DC)

KW - Inhibitory effect

KW - Myeloid progenitor cells

KW - W-7

UR - http://www.scopus.com/inward/record.url?scp=0033844404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033844404&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(00)00047-3

DO - 10.1016/S0145-2126(00)00047-3

M3 - Article

C2 - 10996197

AN - SCOPUS:0033844404

VL - 24

SP - 795

EP - 804

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 10

ER -